The article “Where are we with the use of N-acetylcysteine as a preventive and adjuvant treatment for COVID-19?” published on Eur Rev Med Pharmacol Sci by Dr Di Marco et al. analyzes the use of N-acetylcysteine (NAC) as a promising drug for the adjunctive or supportive treatment of serious COVID-19.
In particular, clinical and experimental data suggest that NAC may act on the mechanisms leading to the prothrombotic state observed in severe COVID-19
